SCHEMBL5368924

SCHEMBL5368924

OB(OCCC(c1ccccc1)c1ccccc1)Oc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 6/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
HTR2A P28223 5/20 0.36
MTNR1A P48039 3/20 0.35
MTNR1B P49286 3/20 0.35
HTR1A P08908 1/20 0.34
ADRA1D P25100 1/20 0.34
ADRA1A P35348 1/20 0.34
ADRA1B P35368 1/20 0.34
SCN4A P35499 2/20 0.33
ALDH1A1 P00352 2/20 0.33
EPHX2 P34913 1/20 0.33
RECQL P46063 1/20 0.33
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33
LMNA P02545 1/20 0.33
ALPL P05186 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28346397 0.78 ALDH1A1 (0.52) MEN1KMT2AALDH1A1RECQL
SCHEMBL4860138 0.77 LTA4H (0.40) MEN1KMT2AALDH1A1RECQLLMNA
SCHEMBL4532447 0.77 HRH1 (0.48) HRH1HTR2AMTNR1AMTNR1BEPHX2
SCHEMBL3322808 0.75 HRH1 (0.47) HRH1HTR2AMTNR1AMTNR1BEPHX2
SCHEMBL3729896 0.74 LTA4H (0.50) HRH1HTR2AHTR1ARECQLCNR1
SCHEMBL28088282 0.74 FFAR1 (0.42) LMNA
SCHEMBL15544573 0.74 ALDH1A1 (0.40) MEN1KMT2AALDH1A1RECQLLMNA
SCHEMBL4849454 0.72 LTA4H (0.50) HRH1HTR2AHTR1AALDH1A1CNR1
Boric Acid SCHEMBL28209851 0.72 LTA4H (0.49) HRH1HTR2AHTR1ARECQLCNR1
SCHEMBL5381406 0.72 IDO1 (0.47) ADRA1AEPHX2RECQLLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259842-A1 Intracellular calcuim concentration increase inhibitors MIKOSHIBA, KATSUHIKO (JP) 2004-12-23 US claimed
EP-1444981-A1 INTRACELLULAR CALCIUM CONCENTRATION INCREASE INHIBITORS Mikoshiba, Katsuhiko (JP) 2004-08-11 EP claimed
US-7217701-B2 Intracellular calcium concentration increase inhibitors KATSUHIKO MIKOSHIBA (JP) 2007-05-15 US disclosed
US-20040259842-A1 Intracellular calcuim concentration increase inhibitors MIKOSHIBA, KATSUHIKO (JP) 2004-12-23 US disclosed
EP-1444981-A1 INTRACELLULAR CALCIUM CONCENTRATION INCREASE INHIBITORS Mikoshiba, Katsuhiko (JP) 2004-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259842-A1 Intracellular calcuim concentration increase inhibitors CAB39, BPGM, ORAI1 HRH1 1005/4885MEN1 599/4885KMT2A 4827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.